ATOMWISE Trademark

Trademark Overview


On Monday, May 24, 2021, a trademark application was filed for ATOMWISE with the United States Patent and Trademark Office. The USPTO has given the ATOMWISE trademark a serial number of 90731554. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Friday, May 2, 2025. This trademark is owned by Atomwise Inc.. The ATOMWISE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, namely, anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical p...
atomwise

General Information


Serial Number90731554
Word MarkATOMWISE
Filing DateMonday, May 24, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateFriday, May 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 20, 2022

Trademark Statements


Goods and Servicespharmaceuticals, namely, anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceuticals for the treatment of rare diseases, vascular diseases and conditions, neurologic diseases and conditions, rheumatology conditions and diseases, and psychiatric conditions and diseases; chemical preparations and biological preparations for the treatment of diseases and disorders; herbicides, insecticides and pesticides
Pseudo MarkATOM WISE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAtomwise Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94103

Party NameAtomwise Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94103

Trademark Events


Event DateEvent Description
Thursday, May 27, 2021NEW APPLICATION ENTERED
Tuesday, August 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Friday, February 11, 2022NON-FINAL ACTION WRITTEN
Friday, February 11, 2022NON-FINAL ACTION E-MAILED
Friday, February 11, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 12, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 31, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 2, 2023SOU EXTENSION 1 FILED
Tuesday, May 2, 2023SOU EXTENSION 1 GRANTED
Thursday, May 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 6, 2023SOU EXTENSION 2 FILED
Monday, November 6, 2023SOU EXTENSION 2 GRANTED
Tuesday, May 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 7, 2024SOU EXTENSION 4 FILED
Monday, May 6, 2024SOU EXTENSION 3 GRANTED
Monday, May 6, 2024SOU EXTENSION 3 FILED
Monday, May 6, 2024SOU TEAS EXTENSION RECEIVED
Thursday, November 7, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 26, 2024SOU EXTENSION 4 GRANTED
Tuesday, November 26, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 1, 2025SOU EXTENSION 5 FILED
Thursday, May 1, 2025SOU TEAS EXTENSION RECEIVED
Friday, May 2, 2025SOU EXTENSION 5 GRANTED
Friday, May 2, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED